Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis

The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis Vol. 23; no. 5; pp. 704 - 710
Main Authors: Motl, Robert W, Cohen, Jeffrey A, Benedict, Ralph, Phillips, Glenn, LaRocca, Nicholas, Hudson, Lynn D, Rudick, Richard
Format: Journal Article
Language:English
Published: England 01.04.2017
Subjects:
ISSN:1477-0970
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with multiple sclerosis (MS). One of the MSOAC goals is acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful in MS. This article addresses the history, application, and psychometric properties of one such MSOAC metric of ambulation or walking namely, the timed 25-foot walk (T25FW). The T25FW has strong reliability over both brief and long periods of time in MS across a large range of disability levels. The outcome of walking speed from the T25FW has obvious real-world relevance and has correlated strongly with other measures of walking and lower extremity function. The T25FW is responsive for capturing intervention effects in pharmacological and rehabilitation trials and has an established value for capturing clinically meaningful change in ambulation. Directions for future research involve validating clinically meaningful improvements on the T25FW as well as determining whether 20% change is clinically meaningful across the disability spectrum. Researchers might further consider synchronizing accelerometers and motion sensors with the T25FW for capturing walking speed in everyday life and the patient's real environment.
AbstractList The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institute of Neurological Disorders and Stroke (NINDS), academic institutions, and industry partners along with persons living with multiple sclerosis (MS). One of the MSOAC goals is acceptance and qualification by regulators of performance outcomes that are highly reliable and valid, practical, cost-effective, and meaningful in MS. This article addresses the history, application, and psychometric properties of one such MSOAC metric of ambulation or walking namely, the timed 25-foot walk (T25FW). The T25FW has strong reliability over both brief and long periods of time in MS across a large range of disability levels. The outcome of walking speed from the T25FW has obvious real-world relevance and has correlated strongly with other measures of walking and lower extremity function. The T25FW is responsive for capturing intervention effects in pharmacological and rehabilitation trials and has an established value for capturing clinically meaningful change in ambulation. Directions for future research involve validating clinically meaningful improvements on the T25FW as well as determining whether 20% change is clinically meaningful across the disability spectrum. Researchers might further consider synchronizing accelerometers and motion sensors with the T25FW for capturing walking speed in everyday life and the patient's real environment.
Author LaRocca, Nicholas
Phillips, Glenn
Benedict, Ralph
Motl, Robert W
Hudson, Lynn D
Cohen, Jeffrey A
Rudick, Richard
AuthorAffiliation Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA
AuthorAffiliation_xml – name: Multiple Sclerosis Outcome Assessments Consortium (MSOAC), Critical Path Institute, Tucson, AZ, USA
Author_xml – sequence: 1
  givenname: Robert W
  surname: Motl
  fullname: Motl, Robert W
  organization: Department of Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, USA
– sequence: 2
  givenname: Jeffrey A
  surname: Cohen
  fullname: Cohen, Jeffrey A
  organization: Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
– sequence: 3
  givenname: Ralph
  surname: Benedict
  fullname: Benedict, Ralph
  organization: Department of Neurology, University at Buffalo, Buffalo, NY, USA
– sequence: 4
  givenname: Glenn
  surname: Phillips
  fullname: Phillips, Glenn
  organization: Biogen, Cambridge, MA, USA
– sequence: 5
  givenname: Nicholas
  surname: LaRocca
  fullname: LaRocca, Nicholas
  organization: National Multiple Sclerosis Society, New York, NY, USA
– sequence: 6
  givenname: Lynn D
  surname: Hudson
  fullname: Hudson, Lynn D
  organization: Critical Path Institute, Tucson, AZ, USA
– sequence: 7
  givenname: Richard
  surname: Rudick
  fullname: Rudick, Richard
  organization: Biogen, Cambridge, MA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28206828$$D View this record in MEDLINE/PubMed
BookMark eNo1kE1LxDAURYMojjO6dyVZuqkmL22TLGXwCwbcqNuSpi9YTZrapMj8ewuOq7u4hwv3rMnxEAck5JKzG86lvOWigrJSFZe1ZgrEETnjpZQF05KtyDqlT8aYlKI6JStQwGoF6oy4d-P7rs97Gh3NH0hzH7CjUBUuxkx_jP-iJlEzUBPa2Zscpz0dcXJxCmawSOOcbQxIA5o0T0iXgobZ5370SJP1OMXUp3Ny4oxPeHHIDXl7uH_dPhW7l8fn7d2usJWAXGgnOqwlgOscZ9qq1qJwphQOwIiFaasSOlG3pYa205phx5w1kiG2WukSNuT6b3ec4veMKTehTxa9NwPGOTVcLXI01IIt6NUBndvlcjNOfTDTvvl3A7_EE2eM
CitedBy_id crossref_primary_10_1007_s11332_019_00545_1
crossref_primary_10_1016_j_msard_2020_102390
crossref_primary_10_3390_s21093075
crossref_primary_10_1186_s12883_024_03871_1
crossref_primary_10_1136_bmjopen_2022_062160
crossref_primary_10_1177_13524585241260145
crossref_primary_10_1007_s00415_017_8676_8
crossref_primary_10_3390_s23073407
crossref_primary_10_3390_s21072259
crossref_primary_10_1016_j_msard_2021_103400
crossref_primary_10_1007_s00415_020_09759_7
crossref_primary_10_1016_j_msard_2022_104216
crossref_primary_10_1016_j_apmr_2025_05_005
crossref_primary_10_1016_j_msard_2022_103802
crossref_primary_10_1177_20552173211061547
crossref_primary_10_1212_WNL_0000000000213558
crossref_primary_10_3389_fneur_2018_00386
crossref_primary_10_1177_1352458519872465
crossref_primary_10_1212_WNL_0000000000207301
crossref_primary_10_1177_1352458519876701
crossref_primary_10_1002_acn3_51996
crossref_primary_10_1002_pri_70103
crossref_primary_10_1097_TGR_0000000000000233
crossref_primary_10_3389_fneur_2020_00700
crossref_primary_10_1016_j_gaitpost_2020_11_025
crossref_primary_10_3389_fneur_2018_00718
crossref_primary_10_1016_j_cct_2024_107584
crossref_primary_10_1016_j_msard_2023_104624
crossref_primary_10_1177_1352458517690825
crossref_primary_10_3389_fnhum_2021_639269
crossref_primary_10_1177_13524585211035333
crossref_primary_10_3389_fneur_2021_608491
crossref_primary_10_1016_j_msard_2023_105394
crossref_primary_10_7224_1537_2073_2023_108
crossref_primary_10_1186_s12984_023_01266_w
crossref_primary_10_1155_2019_6430596
crossref_primary_10_3389_fneur_2024_1379712
crossref_primary_10_1016_j_msard_2023_104710
crossref_primary_10_1371_journal_pone_0220613
crossref_primary_10_1016_j_msard_2022_104433
crossref_primary_10_1007_s00415_023_12099_x
crossref_primary_10_1007_s12325_019_00958_x
crossref_primary_10_1016_j_trci_2019_06_007
crossref_primary_10_1080_00207454_2022_2090353
crossref_primary_10_3390_diagnostics15070936
crossref_primary_10_3389_fneur_2022_878313
crossref_primary_10_1111_ene_15163
crossref_primary_10_1111_jon_13064
crossref_primary_10_1186_s12883_020_1611_0
crossref_primary_10_1111_ane_13441
crossref_primary_10_1016_j_bandc_2025_106349
crossref_primary_10_1016_j_jocn_2020_10_034
crossref_primary_10_1177_20552173211015503
crossref_primary_10_3390_cells14130969
crossref_primary_10_3390_biom11091342
crossref_primary_10_3390_ijerph192416989
crossref_primary_10_1016_j_msard_2024_105679
crossref_primary_10_1109_JBHI_2020_2998187
crossref_primary_10_3389_fneur_2023_1172419
crossref_primary_10_1080_14737175_2018_1510772
crossref_primary_10_1016_j_msard_2019_06_019
crossref_primary_10_1155_ane_5593383
crossref_primary_10_1177_1352458517745725
crossref_primary_10_1007_s40273_020_00964_w
crossref_primary_10_1177_13524585211017013
crossref_primary_10_1016_j_jelekin_2021_102607
crossref_primary_10_1016_j_msard_2024_105439
crossref_primary_10_1016_j_nicl_2021_102653
crossref_primary_10_1016_j_msard_2025_106380
crossref_primary_10_1177_15459683241260724
crossref_primary_10_1177_13524585231187283
crossref_primary_10_1016_j_cct_2019_04_013
crossref_primary_10_1177_1352458517723718
crossref_primary_10_1007_s00415_020_09965_3
crossref_primary_10_1111_ane_13313
crossref_primary_10_3390_cells8111439
crossref_primary_10_1177_13524585231152433
crossref_primary_10_1007_s00415_019_09500_z
crossref_primary_10_1007_s40263_024_01132_w
crossref_primary_10_1016_j_msard_2021_103165
crossref_primary_10_1016_j_msard_2025_106713
crossref_primary_10_3233_NRE_201535
crossref_primary_10_1080_09593985_2021_1978118
crossref_primary_10_1097_NPT_0000000000000529
crossref_primary_10_1177_13524585221094224
crossref_primary_10_1016_j_cct_2019_105878
crossref_primary_10_1080_10543406_2023_2280557
crossref_primary_10_1016_j_cct_2017_07_016
crossref_primary_10_1016_j_msard_2022_103842
crossref_primary_10_1016_j_jns_2024_123073
crossref_primary_10_1212_CPJ_0000000000000918
crossref_primary_10_1016_j_msard_2022_103725
crossref_primary_10_1016_j_msard_2022_103718
crossref_primary_10_1016_j_msard_2020_101941
crossref_primary_10_1002_sim_9625
crossref_primary_10_1177_15459683231206741
crossref_primary_10_1177_1352458520987539
crossref_primary_10_3389_fneur_2021_758710
crossref_primary_10_1159_000547176
crossref_primary_10_1016_j_msard_2025_106271
crossref_primary_10_1002_ana_26239
crossref_primary_10_1016_j_msard_2022_104242
crossref_primary_10_1038_s41582_024_01023_0
crossref_primary_10_1016_j_msard_2025_106722
crossref_primary_10_1016_j_neuropsychologia_2018_05_007
crossref_primary_10_1080_14737175_2025_2450788
crossref_primary_10_1111_ene_15220
crossref_primary_10_1186_s12938_022_00992_x
crossref_primary_10_1007_s40263_018_0530_8
crossref_primary_10_1177_1352458518807076
crossref_primary_10_1371_journal_pone_0189281
crossref_primary_10_3389_fimmu_2024_1362629
crossref_primary_10_1097_NPT_0000000000000505
crossref_primary_10_3389_fneur_2023_1247532
crossref_primary_10_3390_app12147223
crossref_primary_10_1016_j_msard_2019_01_028
crossref_primary_10_1016_j_explore_2020_07_013
crossref_primary_10_1016_j_msard_2022_103702
crossref_primary_10_3390_brainsci15030274
crossref_primary_10_1016_j_cmpb_2022_107204
crossref_primary_10_1177_1352458517729465
crossref_primary_10_1212_WNL_0000000000213332
crossref_primary_10_1080_01616412_2025_2484426
crossref_primary_10_1016_j_conctc_2024_101279
crossref_primary_10_1177_2055217318783766
crossref_primary_10_1080_09593985_2023_2299726
crossref_primary_10_1177_1352458519881991
crossref_primary_10_1177_20552076231205284
crossref_primary_10_1016_j_heliyon_2022_e10259
crossref_primary_10_1186_s12955_023_02190_2
crossref_primary_10_3389_fneur_2017_00433
crossref_primary_10_1038_s41598_020_79095_3
crossref_primary_10_1038_s41598_025_10830_4
crossref_primary_10_1016_j_clinbiomech_2022_105826
crossref_primary_10_1371_journal_pone_0222288
crossref_primary_10_1212_CPJ_0000000000200184
crossref_primary_10_3389_fnbeh_2018_00296
crossref_primary_10_1159_000531860
crossref_primary_10_1016_j_msard_2018_08_020
crossref_primary_10_1016_S1474_4422_20_30277_5
crossref_primary_10_1016_j_apmr_2025_02_005
crossref_primary_10_1016_j_msard_2024_105598
crossref_primary_10_1111_ene_15920
crossref_primary_10_1111_nyas_14777
crossref_primary_10_1016_j_jns_2020_116978
crossref_primary_10_1177_13524585231187521
crossref_primary_10_7705_biomedica_6873
crossref_primary_10_1111_ene_14162
crossref_primary_10_1177_2055217317753465
crossref_primary_10_1177_13524585241274607
crossref_primary_10_14309_ajg_0000000000002630
crossref_primary_10_1016_j_jshs_2018_06_008
crossref_primary_10_1136_bmjopen_2024_097970
crossref_primary_10_3390_healthcare12010010
crossref_primary_10_1177_13524585221125372
crossref_primary_10_1016_j_msard_2021_103360
crossref_primary_10_1016_j_msard_2022_103640
crossref_primary_10_1016_j_msard_2022_103644
crossref_primary_10_1177_13524585231214362
crossref_primary_10_1177_1352458518796690
crossref_primary_10_1155_2024_4882755
crossref_primary_10_2196_44428
crossref_primary_10_3390_sclerosis3030022
crossref_primary_10_1177_1352458519898108
crossref_primary_10_1212_WNL_0000000000011863
crossref_primary_10_1212_WNL_0000000000011862
crossref_primary_10_1007_s13311_022_01246_3
crossref_primary_10_1097_WNP_0000000000000431
crossref_primary_10_3390_neurolint17070112
crossref_primary_10_1016_j_cct_2024_107621
crossref_primary_10_2196_30394
crossref_primary_10_2196_58026
crossref_primary_10_1016_j_msard_2022_103998
crossref_primary_10_1177_13524585241273054
crossref_primary_10_1038_s41582_019_0183_3
crossref_primary_10_1038_s41746_024_01025_8
crossref_primary_10_3390_ijerph18020498
crossref_primary_10_1038_s41598_018_22676_0
crossref_primary_10_1002_acn3_51354
crossref_primary_10_1016_j_msard_2022_103519
crossref_primary_10_1038_s41582_020_00448_7
crossref_primary_10_1212_CPJ_0000000000000382
crossref_primary_10_1080_09593985_2021_1931590
crossref_primary_10_3390_brainsci14030277
crossref_primary_10_1177_15459683251318246
crossref_primary_10_1089_jicm_2022_0610
crossref_primary_10_1186_s13104_023_06316_z
crossref_primary_10_1038_s41598_020_69667_8
crossref_primary_10_1080_23279095_2018_1448818
crossref_primary_10_1038_s41598_021_92776_x
crossref_primary_10_1016_j_jneuroim_2025_578613
crossref_primary_10_1038_s41598_025_05048_3
crossref_primary_10_1177_15459683221076461
crossref_primary_10_1097_WNN_0000000000000179
crossref_primary_10_1177_1352458520914822
crossref_primary_10_1016_j_msard_2023_104552
crossref_primary_10_3389_fneur_2025_1563041
crossref_primary_10_1186_s12883_023_03436_8
crossref_primary_10_1007_s00415_020_09696_5
crossref_primary_10_1177_13524585251335213
crossref_primary_10_7224_1537_2073_2023_091
crossref_primary_10_1177_1352458518754716
crossref_primary_10_3389_fnins_2020_582046
crossref_primary_10_7717_peerj_9303
crossref_primary_10_1016_j_apmr_2020_10_122
crossref_primary_10_3389_fnhum_2024_1449388
crossref_primary_10_1111_jnp_12285
crossref_primary_10_2147_DNND_S384038
crossref_primary_10_3390_s25061780
crossref_primary_10_1212_CON_0000000000000727
crossref_primary_10_1177_13524585211063623
crossref_primary_10_1097_NPT_0000000000000439
crossref_primary_10_1007_s00221_025_07156_y
crossref_primary_10_3390_neurolint17050063
crossref_primary_10_7224_1537_2073_2021_130
crossref_primary_10_1093_ptj_pzaa227
crossref_primary_10_2196_19598
crossref_primary_10_1177_1545968317753681
crossref_primary_10_1016_j_msard_2024_105715
crossref_primary_10_3390_s23136017
crossref_primary_10_2217_nmt_2018_0016
crossref_primary_10_1177_1352458520983584
crossref_primary_10_1080_09638288_2018_1496154
crossref_primary_10_1159_000512513
crossref_primary_10_1177_1352458520936231
crossref_primary_10_1136_bmjopen_2024_085241
crossref_primary_10_1007_s00415_019_09489_5
crossref_primary_10_1186_s12883_023_03513_y
crossref_primary_10_3389_fneur_2020_00735
crossref_primary_10_1007_s00415_022_11171_2
crossref_primary_10_1016_j_csbj_2025_05_003
crossref_primary_10_3233_NRE_182498
crossref_primary_10_1016_j_ncl_2023_07_002
crossref_primary_10_1016_j_jns_2023_122781
crossref_primary_10_7224_1537_2073_2018_001
crossref_primary_10_1186_s13102_023_00790_5
crossref_primary_10_3390_life13071501
crossref_primary_10_1152_jn_00373_2022
crossref_primary_10_1177_13524585231189671
crossref_primary_10_1016_j_msard_2025_106674
crossref_primary_10_1097_NPT_0000000000000497
crossref_primary_10_1177_15459683231167850
crossref_primary_10_1007_s00415_018_9075_5
crossref_primary_10_1016_j_msard_2022_104094
crossref_primary_10_1177_13524585241282763
crossref_primary_10_1007_s10548_021_00858_w
crossref_primary_10_1007_s11910_019_0997_9
crossref_primary_10_1016_j_msard_2023_105354
crossref_primary_10_1016_j_msard_2024_105731
crossref_primary_10_1002_jmri_27389
crossref_primary_10_1080_01616412_2023_2252283
crossref_primary_10_1136_bmjopen_2020_043699
crossref_primary_10_3390_app14177906
crossref_primary_10_7224_1537_2073_2020_114
crossref_primary_10_1007_s00415_022_11306_5
crossref_primary_10_3390_brainsci12010063
crossref_primary_10_1007_s00415_025_13066_4
crossref_primary_10_1016_j_gaitpost_2025_03_011
crossref_primary_10_1080_01616412_2024_2338033
crossref_primary_10_1016_j_apmr_2023_06_019
crossref_primary_10_1016_j_msard_2020_102186
crossref_primary_10_1177_2055217320964940
crossref_primary_10_1136_bmjopen_2023_073782
crossref_primary_10_1177_13524585221105465
crossref_primary_10_1097_WCO_0000000000000928
crossref_primary_10_1177_20552173231202123
crossref_primary_10_1016_j_msard_2019_07_003
crossref_primary_10_1038_s41598_021_92353_2
crossref_primary_10_2196_63090
crossref_primary_10_1007_s00415_023_11945_2
crossref_primary_10_1016_j_msard_2021_102808
crossref_primary_10_1177_1352458518815795
crossref_primary_10_3390_app14146193
crossref_primary_10_1038_s41598_024_62726_4
crossref_primary_10_1177_13524585231190771
crossref_primary_10_1080_07853890_2023_2252439
crossref_primary_10_36290_neu_2022_032
crossref_primary_10_3389_fnins_2023_1231321
crossref_primary_10_1212_WNL_0000000000011123
crossref_primary_10_7224_1537_2073_2020_133
crossref_primary_10_1016_j_msard_2024_105630
crossref_primary_10_1109_JIOT_2025_3545744
crossref_primary_10_17826_cumj_631595
crossref_primary_10_3390_pharmacy8020061
crossref_primary_10_1007_s00415_021_10674_8
crossref_primary_10_3390_neurolint14020035
crossref_primary_10_1017_S1355617723000371
crossref_primary_10_1016_j_msard_2021_102946
crossref_primary_10_1177_20552173221099186
crossref_primary_10_1016_j_apmr_2019_08_488
crossref_primary_10_1212_WNL_0000000000012690
crossref_primary_10_1016_j_msard_2025_106343
crossref_primary_10_1212_WNL_0000000000008519
crossref_primary_10_3389_fneur_2022_907245
crossref_primary_10_1016_j_msard_2025_106462
crossref_primary_10_3390_biomedicines7030056
crossref_primary_10_1007_s00415_021_10750_z
crossref_primary_10_1080_09602011_2018_1449758
ContentType Journal Article
CorporateAuthor Multiple Sclerosis Outcome Assessments Consortium
CorporateAuthor_xml – name: Multiple Sclerosis Outcome Assessments Consortium
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/1352458517690823
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0970
EndPage 710
ExternalDocumentID 28206828
Genre Journal Article
GroupedDBID ---
-TM
.2E
.2F
.2G
.2J
.2N
01A
0R~
123
18M
1~K
29M
31R
31S
31U
31X
31Y
31Z
36B
39C
4.4
53G
54M
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AANSI
AAPEO
AAQDB
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWC
ABAWP
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHFT
ABHKI
ABHQH
ABJIS
ABJNI
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEIA
ADMPF
ADNBR
ADNMO
ADNON
ADRRZ
ADTBJ
ADUCT
ADUKL
ADVBO
ADYCS
ADZYD
ADZZY
AECGH
AECVZ
AEDTQ
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFQAA
AFUIA
AFVCE
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGWFA
AGWNL
AHDMH
AHHFK
AHMBA
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
ALTZF
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
CAG
CBRKF
CCPQU
CDWPY
CFDXU
CGR
COF
CORYS
CQQTX
CS3
CUTAK
CUY
CVF
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EBS
ECM
EIF
EJD
EMOBN
F5P
FD6
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
K.J
K9-
M0R
M1P
M4V
N9A
NPM
O9-
P.B
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SAUOL
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
UKHRP
XJT
ZONMY
ZPPRI
ZRKOI
ZSSAH
7X8
AAPII
ABIDT
ABJZC
ADEBD
AJGYC
AJHME
AJVBE
SASJQ
ID FETCH-LOGICAL-c532t-9f3de6722fdf109c8bce3fa43f22a3c53b542d36b492bd990ed0fca70eeb98942
IEDL.DBID 7X8
ISICitedReferencesCount 316
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000399859300013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
IngestDate Sun Sep 28 02:44:31 EDT 2025
Thu Apr 03 06:56:50 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords validity
Ambulation
gait
multiple sclerosis
walking
reliability
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c532t-9f3de6722fdf109c8bce3fa43f22a3c53b542d36b492bd990ed0fca70eeb98942
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://journals.sagepub.com/doi/full/10.1177/1352458517690823
PMID 28206828
PQID 1869092630
PQPubID 23479
PageCount 7
ParticipantIDs proquest_miscellaneous_1869092630
pubmed_primary_28206828
PublicationCentury 2000
PublicationDate 2017-04-01
PublicationDateYYYYMMDD 2017-04-01
PublicationDate_xml – month: 04
  year: 2017
  text: 2017-04-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Multiple sclerosis
PublicationTitleAlternate Mult Scler
PublicationYear 2017
References 28206813 - Mult Scler. 2017 Apr;23(5):626-627
References_xml – reference: 28206813 - Mult Scler. 2017 Apr;23(5):626-627
SSID ssj0007735
Score 2.6246998
SecondaryResourceType review_article
Snippet The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) includes representatives from advocacy organizations, Food and Drug Administration (FDA),...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 704
SubjectTerms Adult
Disability Evaluation
Exercise Test - methods
Female
Humans
Male
Middle Aged
Multiple Sclerosis - physiopathology
Multiple Sclerosis - rehabilitation
Outcome Assessment (Health Care)
Reproducibility of Results
Walking - physiology
Title Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis
URI https://www.ncbi.nlm.nih.gov/pubmed/28206828
https://www.proquest.com/docview/1869092630
Volume 23
WOSCitedRecordID wos000399859300013&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3NS8MwFA_qRLz4_TG_iOC1LEvapjmJiMPLxg4qu5V8wlCbuXaK_70vbcdOguCllzQkpC95v7zf6_shdONIZogG5AYGRKKYchcpZ2C7i0yQWIOLk6oWm-CjUTaZiHEbcCvbtMrlmVgf1MbrECPv1dJJgqaM3M4-oqAaFdjVVkJjHXUYQJlg1XyyqhbOOUtW1GSvD2AjDjQYT2uh799BZe1cBrv_ndYe2mlhJb5r7GAfrdniAG0NW-L8ELkXwNsGEDf2DgPmw0FT3mCaRM77Cn_Jt1csSywLLN9VUPTy8288W_1UgP2igglZ_N7EFDE04GUyIi5hTPC20_IIPQ8enu4fo1ZiIdIJo1UkHDM25ZQ64_pE6Expy5yMmaNUMnhHJTE1LFWxoMqA57KGOC05sVaF0u30GG0UvrCnCFvlqKBaQXcNty6uZGwy5xJFgmaVSrvoermCOZhw4CVkYf2izFdr2EUnzWfIZ02tjZyG-vJwKzz7Q-9ztE2D063zai5Qx8EGtpdoU39W03J-VdsGPEfj4Q-ppcdc
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validity+of+the+timed+25-foot+walk+as+an+ambulatory+performance+outcome+measure+for+multiple+sclerosis&rft.jtitle=Multiple+sclerosis&rft.au=Motl%2C+Robert+W&rft.au=Cohen%2C+Jeffrey+A&rft.au=Benedict%2C+Ralph&rft.au=Phillips%2C+Glenn&rft.date=2017-04-01&rft.eissn=1477-0970&rft.volume=23&rft.issue=5&rft.spage=704&rft_id=info:doi/10.1177%2F1352458517690823&rft_id=info%3Apmid%2F28206828&rft_id=info%3Apmid%2F28206828&rft.externalDocID=28206828